Jamie Stockton
Stock Analyst at Wells Fargo
(2.26)
# 2,781
Out of 5,036 analysts
22
Total ratings
46.67%
Success rate
10.81%
Average return
Main Sectors:
Stocks Rated by Jamie Stockton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $175 → $200 | $8.66 | +2,209.47% | 5 | Oct 29, 2020 | |
| OMCL Omnicell | Maintains: Equal-Weight | $74 → $84 | $30.98 | +171.14% | 2 | Oct 28, 2020 | |
| HQY HealthEquity | Maintains: Overweight | $63 → $70 | $96.00 | -27.08% | 6 | Sep 9, 2020 | |
| EVH Evolent Health | Maintains: Overweight | $19 → $17 | $8.18 | +107.82% | 2 | Jan 8, 2020 | |
| MMS Maximus | Maintains: Equal-Weight | $83 → $81 | $87.71 | -7.65% | 3 | Jan 8, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | $140 → $160 | $218.67 | -26.83% | 2 | Feb 19, 2019 | |
| EHTH eHealth | Maintains: Market Perform | $18 → $24 | $5.21 | +360.65% | 2 | Oct 19, 2017 |
Teladoc Health
Oct 29, 2020
Maintains: Equal-Weight
Price Target: $175 → $200
Current: $8.66
Upside: +2,209.47%
Omnicell
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $74 → $84
Current: $30.98
Upside: +171.14%
HealthEquity
Sep 9, 2020
Maintains: Overweight
Price Target: $63 → $70
Current: $96.00
Upside: -27.08%
Evolent Health
Jan 8, 2020
Maintains: Overweight
Price Target: $19 → $17
Current: $8.18
Upside: +107.82%
Maximus
Jan 8, 2020
Maintains: Equal-Weight
Price Target: $83 → $81
Current: $87.71
Upside: -7.65%
IQVIA Holdings
Feb 19, 2019
Maintains: Outperform
Price Target: $140 → $160
Current: $218.67
Upside: -26.83%
eHealth
Oct 19, 2017
Maintains: Market Perform
Price Target: $18 → $24
Current: $5.21
Upside: +360.65%